Cargando…
COVID-19-related autoimmune disorders of central nervous system (CRAD-C): Is it a new entity?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253721/ https://www.ncbi.nlm.nih.gov/pubmed/34229045 http://dx.doi.org/10.1016/j.autrev.2021.102888 |
| _version_ | 1783717574195806208 |
|---|---|
| author | Naser Moghadasi, Abdorreza |
| author_facet | Naser Moghadasi, Abdorreza |
| author_sort | Naser Moghadasi, Abdorreza |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8253721 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82537212021-07-06 COVID-19-related autoimmune disorders of central nervous system (CRAD-C): Is it a new entity? Naser Moghadasi, Abdorreza Autoimmun Rev Article Elsevier B.V. 2021-09 2021-07-03 /pmc/articles/PMC8253721/ /pubmed/34229045 http://dx.doi.org/10.1016/j.autrev.2021.102888 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Naser Moghadasi, Abdorreza COVID-19-related autoimmune disorders of central nervous system (CRAD-C): Is it a new entity? |
| title | COVID-19-related autoimmune disorders of central nervous system (CRAD-C): Is it a new entity? |
| title_full | COVID-19-related autoimmune disorders of central nervous system (CRAD-C): Is it a new entity? |
| title_fullStr | COVID-19-related autoimmune disorders of central nervous system (CRAD-C): Is it a new entity? |
| title_full_unstemmed | COVID-19-related autoimmune disorders of central nervous system (CRAD-C): Is it a new entity? |
| title_short | COVID-19-related autoimmune disorders of central nervous system (CRAD-C): Is it a new entity? |
| title_sort | covid-19-related autoimmune disorders of central nervous system (crad-c): is it a new entity? |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253721/ https://www.ncbi.nlm.nih.gov/pubmed/34229045 http://dx.doi.org/10.1016/j.autrev.2021.102888 |
| work_keys_str_mv | AT nasermoghadasiabdorreza covid19relatedautoimmunedisordersofcentralnervoussystemcradcisitanewentity |